Immunological differences between primary and metastatic breast cancer. Homo sapiens

Little is known about how the immune microenvironment of breast cancer evolves during disease progression. The goal of this project was to examine immune gene mRNA expression in primary tumors (P) and metastatic lesions (M). The expression of 730 immune-related genes was measured using the Nanostring PanCancer Immune Gene Panel. Overall design: Expression of 730 immune-related genes were measured in 31 P and 17 M, including 10 paired cases.